Related Experiment Video
Updated: Jun 6, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Transcriptional regulation of HIV-1 gene expression by p53
Ruma Mukerjee1, Pier Paolo Claudio, J Robert Chang
1Molecular Virology Lab, Department of Neurology, Temple University School of Medicine, Philadelphia, PA, USA.
Abstract:
Several reports have pointed to the negative involvement of p53 in transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat (HIV-1 LTR). However, the mechanisms of this negative effect remain unclear. In here, we showed that over expression of p53 wild type prevented the phosphorylation of serine 2 in the carboxyl terminal domain (CTD) of RNA polymerase II. As a result of this inhibition, p53 stalled transcriptional elongation on the HIV-1 LTR leading to a significant reduction of HIV-1 replication in primary microglia and astrocytes. However, despite the delay/pause caused by p53, viral transcription and replication decreased and then salvaged. These studies suggest that the negative effect of p53 is alleviated by a third factor. In this regard, our Preliminary Data point to the involvement of the Pirh2 protein in p53 inhibition. Therefore, we suggest that p53 may be a novel therapeutic target for the inhibition of HIV-1 gene expression and replication and the treatment of AIDS.
Insights
The tumor suppressor p53 inhibits human immunodeficiency virus type 1 (HIV-1) replication by blocking RNA polymerase II phosphorylation. This p53-mediated inhibition of HIV-1 transcription and replication suggests p53 as a potential therapeutic target for AIDS treatment.
Area of Science:
- Molecular Biology
- Virology
- Immunology
Background:
- The human immunodeficiency virus type 1 long terminal repeat (HIV-1 LTR) is crucial for viral replication.
- Previous studies suggest p53 negatively regulates HIV-1 LTR transcription, but the mechanism is unclear.
Purpose of the Study:
- To elucidate the mechanism by which p53 inhibits HIV-1 transcription and replication.
- To investigate p53's role in regulating RNA polymerase II activity during HIV-1 infection.
Main Methods:
- Overexpression of wild-type p53 in primary microglia and astrocytes.
- Analysis of RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation.
- Assessment of HIV-1 transcriptional elongation and replication.
Main Results:
- Overexpression of p53 prevented serine 2 phosphorylation in the RNA polymerase II CTD.
- p53 significantly stalled transcriptional elongation on the HIV-1 LTR, reducing viral replication.
- HIV-1 transcription and replication were eventually salvaged, suggesting a mitigating factor.
Conclusions:
- p53 inhibits HIV-1 replication by impeding RNA polymerase II-dependent transcriptional elongation.
- The negative effect of p53 on HIV-1 appears to be alleviated by another factor, potentially Pirh2.
- p53 represents a potential therapeutic target for inhibiting HIV-1 gene expression and treating AIDS.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression at Multiple Steps
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle

